Literature DB >> 2401396

Prevalence of hypertension in type 1 (insulin-dependent) diabetes mellitus.

K Nørgaard1, B Feldt-Rasmussen, K Borch-Johnsen, H Saelan, T Deckert.   

Abstract

The prevalence of hypertension in a representative sample (n = 10202) of the Danish general population aged 16-59 years was assessed to 4.4% based on three blood pressure readings. In Type 1 (insulin-dependent) diabetic patients of similar age (n = 1703) the prevalence was determined in a similar way to 14.7% (p less than 0.00001). The excess prevalence in Type 1 diabetic patients was due to hypertension in patients with incipient and clinical nephropathy as the prevalence of hypertension among diabetic patients with normal urinary albumin excretion (essential hypertension) was 3.9%, similar to that observed in the general population. The patients with Type 1 diabetes and essential hypertension had higher systolic (146 +/- 19 vs 133 +/- 18 mm Hg, p less than 0.00001) and diastolic blood pressure (87 +/- 12 vs 79 +/- 7 mm Hg, p less than 0.00001), but less changes in the eye background than patients with incipient nephropathy (urinary albumin excretion 30-300 mg/24 h) (p less than 0.03), indicating that the two groups were also different with respect to other microangiopathic lesions. Patients with essential hypertension were defined as having a normal urinary albumin excretion before and during antihypertensive treatment (if any). They were followed-up for a 58 (6-234) month period. We confirmed that hypertension is more common among Type 1 diabetic patients than in the general population and found the prevalence of essential hypertension similar in Type 1 diabetic patients to the non-diabetic population. This supports our hypothesis that hypertension is very unlikely to be the cause of diabetic nephropathy.

Entities:  

Mesh:

Year:  1990        PMID: 2401396     DOI: 10.1007/bf00404089

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  16 in total

1.  Hypertension in diabetic clinic patients and their siblings.

Authors:  C Kelleher; S M Kingston; D G Barry; M M Cole; J B Ferriss; G Grealy; C Joyce; D J O'Sullivan
Journal:  Diabetologia       Date:  1988-02       Impact factor: 10.122

Review 2.  Etiology and prevalence of hypertension in diabetic patients.

Authors:  D C Simonson
Journal:  Diabetes Care       Date:  1988 Nov-Dec       Impact factor: 19.112

3.  Antihypertensive treatment: long-term reversal of progression of albuminuria in incipient diabetic nephropathy. A longitudinal study of renal function.

Authors:  C K Christensen; C E Mogensen
Journal:  J Diabet Complications       Date:  1987 Apr-Jun

4.  Enzyme immunoassay: an improved determination of urinary albumin in diabetics with incipient nephropathy.

Authors:  B Feldt-Rasmussen; B Dinesen; M Deckert
Journal:  Scand J Clin Lab Invest       Date:  1985-10       Impact factor: 1.713

5.  Hypertension: the major risk factor in juvenile-onset insulin-dependent diabetics.

Authors:  A R Christlieb; J H Warram; A S Królewski; E J Busick; O P Ganda; A C Asmal; J S Soeldner; R F Bradley
Journal:  Diabetes       Date:  1981       Impact factor: 9.461

6.  Converting enzyme inhibition and kidney function in normotensive diabetic patients with persistent microalbuminuria.

Authors:  M Marre; H Leblanc; L Suarez; T T Guyenne; J Ménard; P Passa
Journal:  Br Med J (Clin Res Ed)       Date:  1987-06-06

Review 7.  Albuminuria reflects widespread vascular damage. The Steno hypothesis.

Authors:  T Deckert; B Feldt-Rasmussen; K Borch-Johnsen; T Jensen; A Kofoed-Enevoldsen
Journal:  Diabetologia       Date:  1989-04       Impact factor: 10.122

8.  Declining incidence of persistent proteinuria in type I (insulin-dependent) diabetic patients in Denmark.

Authors:  A Kofoed-Enevoldsen; K Borch-Johnsen; S Kreiner; J Nerup; T Deckert
Journal:  Diabetes       Date:  1987-02       Impact factor: 9.461

9.  Early aggressive antihypertensive treatment reduces rate of decline in kidney function in diabetic nephropathy.

Authors:  H H Parving; A R Andersen; U M Smidt; P A Svendsen
Journal:  Lancet       Date:  1983-05-28       Impact factor: 79.321

10.  Long-term antihypertensive treatment inhibiting progression of diabetic nephropathy.

Authors:  C E Mogensen
Journal:  Br Med J (Clin Res Ed)       Date:  1982-09-11
View more
  28 in total

1.  Causal inference in diabetic nephropathy.

Authors:  J Stephenson
Journal:  Diabetologia       Date:  1991-01       Impact factor: 10.122

2.  Prevalence of hypertension in type 1 (insulin-dependent) diabetes mellitus.

Authors:  G C Viberti; R Trevisan; R Nosadini
Journal:  Diabetologia       Date:  1991-01       Impact factor: 10.122

3.  Prevalence of hypertension in type 1 (insulin-dependent) diabetes mellitus.

Authors:  L O Simpson
Journal:  Diabetologia       Date:  1991-01       Impact factor: 10.122

Review 4.  The role of hypertension in the development of nephropathy in type 1 (insulin-dependent) diabetes mellitus.

Authors:  B Feldt-Rasmussen; K Nørgaard; T Jensen; E Mathiesen; T Deckert
Journal:  Acta Diabetol Lat       Date:  1990 Apr-Jun

Review 5.  ACE inhibitors in patients with diabetes mellitus. Clinical and economic considerations.

Authors:  K Borch-Johnsen
Journal:  Pharmacoeconomics       Date:  1996-05       Impact factor: 4.981

Review 6.  Lisinopril. A review of its pharmacology and use in the management of the complications of diabetes mellitus.

Authors:  K L Goa; M Haria; M I Wilde
Journal:  Drugs       Date:  1997-06       Impact factor: 9.546

7.  NADPH oxidase and PKC contribute to increased Na transport by the thick ascending limb during type 1 diabetes.

Authors:  Jing Yang; Jennifer S Pollock; Pamela K Carmines
Journal:  Hypertension       Date:  2011-12-27       Impact factor: 10.190

Review 8.  The use of ACE inhibitors on diabetic patients without renal disease.

Authors:  Dmitri Kirpichnikov; Nathaniel Winer; James R Sowers
Journal:  Curr Diab Rep       Date:  2002-02       Impact factor: 4.810

Review 9.  Circadian changes in blood pressure and their relationships to the development of microalbuminuria in type 1 diabetic patients.

Authors:  Donn Hogan; Empar Lurbe; M Reza Salabat; Josep Redon; Daniel Batlle
Journal:  Curr Diab Rep       Date:  2002-12       Impact factor: 4.810

Review 10.  The natural progression of kidney injury in young type 1 diabetic patients.

Authors:  Julia M Steinke
Journal:  Curr Diab Rep       Date:  2009-12       Impact factor: 4.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.